Health and Healthcare
5864 Articles
Despite being a small medical laboratory and research firm, TrovaGene offered cover for investors in Monday's session from a downturn…
Alere absolutely skyrocketed in Monday’s regular session following the announcement that it will be acquired by Abbott Laboratories.
A recent Jefferies research note indicates that the multiples for the four largest biotechs have dipped below that of the…
Exelixis shares were rising early Monday following the release of positive results from its late-stage trial of cabozantinib.
24/7 Wall St. has collected three big FDA decisions coming up in February and added some color, along with the…
After the announcement that its Phase 2 trial of Ruxolitinib would be stopped a few analysts took a deeper look…
AbbVie reported mixed fourth-quarter financial results after the markets closed Thursday.
Amgen reported better-than-expected fourth-quarter financial results after the markets closed Thursday.
AbbVie is scheduled to report its fourth-quarter financial results before the markets open Friday.
Celgene reported mixed fourth-quarter financial results before the markets opened on Thursday.
Jefferies has four top biotech picks for 2016 that all have substantial upside and may provide investors with solid alpha…
The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…
Short interest increased in most of these selected biotech stocks for the most recent settlement date.
Medivation, Inc. (NASDAQ: MDVN) was not having a great day on Wednesday. Its shares were seen down 5% or so…
Anthem is the latest health insurance provider to have some concerns around its earnings report.
Our top personal finance-related articles today. Your wallet will thank you later.